Category Archives: Medtronic Infuse
First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January
The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...
Fracking Boom Changing Way of Life in Pennsylvania's Northern Tier
In just a few years, the impact of hydraulic fracturing (fracking) drilling on northeastern Pennsylvania is hard to miss. Thousands of natural gas wells have been opened in that area specifically in the last five years as companies look to exploit the vast Marcellus shale formation about two miles below the ...
Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million
Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...
Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings
Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.
Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage
A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...
Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA
The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...
Actos Bladder Cancer Lawsuit Filed by West Virginia Resident
Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...
First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January
The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...
Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits
An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.
Knee Replacement Patients Should Consider Nickel Allergies before Surgery
Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...
Still Stinging from Infuse Bone Growth Controversy, Medtronic CEO Promises to Ramp Up Medical Device Monitoring
In response to high-profile safety controversies involving its own Infuse Bone Growth product, as well as medical devices marketed by its rivals, Medtronic Inc. has announced that it will ramp up the way it monitors its products in the hopes … Continue reading
Medtronic Infuse Bone Graft Scandals Include Falsified Study Involving Wounded Soldiers
Medtronic Inc.’s Infuse Bone Graft product has been embroiled in controversy for several years now. This past year alone, several studies have called into question the safety of Infuse, and raised serious concerns about the way Medtronic Infuse side effects … Continue reading
Medtronic Infuse May Cause Retrograde Ejaculation, Infertility in Men
A study released last spring linked Medtronic Inc.’s Infuse bone growth protein to male sterility that, in some cases, may be permanent. The study, conducted by frequent Infuse critic, Dr. Eugene Carragee, found that 7.2 percent of the men he … Continue reading
Medtronic Infuse Bone Graft Sales Continue to Sink
It looks like Medtronic’s Infuse Bone Graft troubles are still impacting the medical device maker’s bottom line. Though Medtronic reported a small increase in its third quarter earnings today, its spine business was down 9%, thanks in large part to … Continue reading
Doctors Wary of Medtronic Infuse in Wake of Cancer, Other Controversies
The past several years have raised serious questions about the safety of Medtronic Inc.’s Infuse bone growth product. According to a report from MedCityNews.com, some doctors have already limited their use of Infuse because of concerns that it might cause … Continue reading
Medtronic Infuse Controversy, Lawsuits Gaining Steam
The controversy surrounding the safety of Medtronic’s Infuse bone growth product in spinal fusion and neck surgeries continues to grow. Medtronic Inc. has actively worked to suppress evidence that Infuse (bone morphogenetic protein-2), especially when used for unapproved procedures, is … Continue reading
Questionable Infuse Bone Graft Research Helped Spark Reform at Medical Journals
The controversy surrounding Medtronic Inc.’s Infuse Bone Graft product has sparked reforms that some experts say could bring greater transparency and credibility to the development of new medical devices and drugs. According to a report from the Milwaukee Journal-Sentinel, Medtronic’s … Continue reading
Senators Question Medtronic on Infuse Side Effects
Three U.S. Senators have written to Medtronic Inc., seeking information about the way the company monitors the performance of medical devices once they come to market. According to a report from Minneapolis Star Tribune, the Senators expressed special interest about … Continue reading
Medtronic Infuse Sales Decline as Controversy Grows
In recent months, the controversy surrounding Medtronic Inc.’s Infuse bone growth product has gained momentum. Not only has the device maker been accused of downplaying the serious side effects associated with Infuse, but most recently, a prominent researcher warned that … Continue reading
New Infuse Scandal Could Hit Medtronic Hard, Analyst Says
A Wall Street analyst says the furor over the most recent < "http://www.yourlawyer.com/topics/overview/Medtronic_Infuse_Bone_Graft">Medtronic Infuse scandal could cause the device maker to exit the spine business. According to a Forbes report, Larry Biegelsen of Wells Fargo said the Infuse controversy could … Continue reading
